274 related articles for article (PubMed ID: 33079194)
1. Building Trust to Achieve Confidence in COVID-19 Vaccines.
Opel DJ; Salmon DA; Marcuse EK
JAMA Netw Open; 2020 Oct; 3(10):e2025672. PubMed ID: 33079194
[No Abstract] [Full Text] [Related]
2. Editorial: Vaccination during the COVID-19 pandemic.
Danchin M
Aust J Gen Pract; 2020 Oct; 49(10):621. PubMed ID: 33015675
[No Abstract] [Full Text] [Related]
3. Planning for a COVID-19 Vaccination Program.
Schaffer DeRoo S; Pudalov NJ; Fu LY
JAMA; 2020 Jun; 323(24):2458-2459. PubMed ID: 32421155
[No Abstract] [Full Text] [Related]
4. Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.
Schwartz JL
N Engl J Med; 2020 Oct; 383(18):1703-1705. PubMed ID: 32966716
[No Abstract] [Full Text] [Related]
5. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
McPartlin SO; Morrison J; Rohrig A; Weijer C
BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564
[No Abstract] [Full Text] [Related]
6. COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby.
Fujiwara K; Quinn MA
Int J Gynecol Cancer; 2020 Aug; 30(8):1255. PubMed ID: 32624498
[No Abstract] [Full Text] [Related]
7. COVID-19 vaccination clinical trials should consider multiple doses of BCG.
Ayoub BM
Pharmazie; 2020 Apr; 75(4):159. PubMed ID: 32295694
[No Abstract] [Full Text] [Related]
8. Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.
Trogen B; Oshinsky D; Caplan A
JAMA; 2020 Jun; 323(24):2460-2461. PubMed ID: 32453392
[No Abstract] [Full Text] [Related]
9. COVID-19 vaccines: time to talk about the uncertainties.
Subbarao K
Nature; 2020 Oct; 586(7830):475. PubMed ID: 33082537
[No Abstract] [Full Text] [Related]
10. [Not Available].
Red
MMW Fortschr Med; 2020 Apr; 162(7):56. PubMed ID: 32291653
[No Abstract] [Full Text] [Related]
11. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
Persad G; Emanuel EJ
JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357
[No Abstract] [Full Text] [Related]
12. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
Heininger U
Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
[No Abstract] [Full Text] [Related]
13. Covid-19: Vaccine trials need more transparency to enable scrutiny and earn public trust, say experts.
Mahase E
BMJ; 2020 Oct; 371():m4042. PubMed ID: 33093065
[No Abstract] [Full Text] [Related]
14. A vaccine is not too far for COVID-19.
Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
[No Abstract] [Full Text] [Related]
15. Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
Wang EA; Zenilman J; Brinkley-Rubinstein L
JAMA; 2020 Sep; 324(11):1031-1032. PubMed ID: 32808972
[No Abstract] [Full Text] [Related]
16. Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot.
Rubin EJ; Baden LR; Piot P; Morrissey S
N Engl J Med; 2020 Jul; 383(5):e57. PubMed ID: 32726549
[No Abstract] [Full Text] [Related]
17. After A COVID-19 Vaccine: Collaboration Or Competition?
Meyer H
Health Aff (Millwood); 2020 Nov; 39(11):1856-1860. PubMed ID: 32986500
[TBL] [Abstract][Full Text] [Related]
18. Keeping track of the SARS-CoV-2 vaccine pipeline.
Parker EPK; Shrotri M; Kampmann B
Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
[TBL] [Abstract][Full Text] [Related]
19. Even covid-19 can't kill the anti-vaccination movement.
Megget K
BMJ; 2020 Jun; 369():m2184. PubMed ID: 32499217
[No Abstract] [Full Text] [Related]
20. Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon.
Dawson L; Earl J; Livezey J
J Infect Dis; 2020 Jul; 222(3):514-516. PubMed ID: 32496536
[No Abstract] [Full Text] [Related]
[Next] [New Search]
